From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine
Open Access
- 24 February 2026
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 232, 115835
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (PJT-166052)
- National Sanitarium Association
- Canada First Research Excellence Fund (CFREF-2022-00042)
This publication has 191 references indexed in Scilit:
- AI‐Driven Microphysiological Systems for Advancing Nanoparticle TherapeuticsAdvanced Intelligent Systems, 2025
- Towards Automation in 3D Cell Culture: Selective and Gentle High‐Throughput Handling of Spheroids and Organoids via Novel Pick‐Flow‐Drop PrincipleAdvanced Healthcare Materials, 2024
- Inverse Design of Nanoparticles Using Multi‐Target Machine LearningAdvanced Theory and Simulations, 2021
- Lipid Nanoparticles for Drug DeliveryAdvanced NanoBiomed Research, 2021
- Nanoparticles in the clinic: An update post COVID‐19 vaccinesBioengineering & Translational Medicine, 2021
- Artificial Chemist: An Autonomous Quantum Dot Synthesis BotAdvanced Materials, 2020
- A Microfluidic Tumor‐on‐a‐Chip for Assessing Multifunctional Liposomes' Tumor Targeting and Anticancer EfficacyAdvanced Healthcare Materials, 2019
- Nanocrystals: A perspective on translational research and clinical studiesBioengineering & Translational Medicine, 2018
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016
- Dye‐Loaded Ferritin Nanocages for Multimodal Imaging and Photothermal TherapyAdvanced Materials, 2014